Mandate

Vinge advises HH Ferries

September 21, 2018 EU, Competition and Regulatory

Vinge has advised HH Ferries in an action before the EU General Court in Luxembourg in state aid proceedings which primarily relate to state guarantees.

The General Court approved HH Ferries’ action due to, among other things, the European Commission’s deficient review of the amount and time limits as well as the support measures’ proportionality and necessity and thus set aside the European Commission’s decision. 

Vinge’s team primarily consisted of Martin Johansson at the Brussels office as well as Rikard Azelius and Pär Remnelid at the Skåne office.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026